Modification of blood group A expression in human pancreatic tumor cell lines by inhibitors of N-glycan processing

International Journal of Pancreatology

Volumn 21, Issue 1, 1997, Pages 21-29

  Schaffert, Courtney ^a   Pour, Parviz M ^b   Chaney, William G ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Blood group A; deoxymannojirimycin; endoglycosidases; oligosaccharide processing; pancreatic cancer; swainsonine

Indexed keywords

BLOOD GROUP A ANTIGEN; GLYCAN;

ADENOCARCINOMA; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BLOOD GROUP TYPING; NONHUMAN; PANCREAS CARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; SYRIAN HAMSTER;

ABO BLOOD-GROUP SYSTEM; ANIMALS; CRICETINAE; GLYCOSIDE HYDROLASES; HUMANS; MEMBRANE GLYCOPROTEINS; MESOCRICETUS; PANCREATIC NEOPLASMS; POLYSACCHARIDES; RABBITS; SWAINSONINE; TUMOR CELLS, CULTURED;

EID: 0030893094     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Kloppel G. Pathology of nonendocrine pancreatic tumors, in The Pancreas: Biology, Pathobiology, and Disease, 2nd ed., Go VL, Dima E, Gardner J, Lebenthal E, Reber H, Scheele G, eds. Raven, New York 1993; pp. 871-897.
2. Pour P, Althoff J, Kruger FW, Mohr U. A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)-amine. J Natl Cancer Inst 1977; 58: 1449-1453.
3. Pour PM, Wilson R. Experimental pancreas tumor, in Cancer of the Pancreas, Moosa AR, ed., William and Wilkins, Baltimore 1980; pp. 37-158.
4. Pour PM, Egami H, Chancy WG, Takiyama Y, Tempero M, Schlom J, Colcher D. Comparative studies on antigen expression in human and experimental pancreatic cancer, in Recent Results in Tumor Diagnosis and Therapy, Klapdor R, ed. W. Zuckschwerdt Verlag München, San Francisco, 1990; pp. 293-296.
5. Smit VTHBM, Boot AJM, Smits AMM, Fleuren GJ, Cornelisse CJ, Bos JL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 1988; 16: 7773-7782.
6. Grunewald K, Lyons J, Frohlich A, Feichtinger H, Weger RA, Schwab G, Janssen JWG, Bartram CR. High frequency of Ki-ras-codon-12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989; 43: 1037-1041.
7. Mariyama M, Kishi K, Nakamura K, Obstata H, Nishimura S. Frequency and types of point mutations at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res 1989; 80: 622-626.
8. Nagate Y, Abe M, Motoshima K, Nakayama E, Shiku H. Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese. Jpn J Cancer Res 1990; 81: 135-140.
9. Cerny WL, Mangold KA, Scarpelli DG. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian Golden hamster. Cancer Res 1992; 52: 4507-4513.
10. Fujii H, Egami H, Chaney WG, Pour P, Pelling J. Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Mol Carcinog 1990; 3: 296-301.
11. van Kranen HJ, Vermeulen E, Schoren L, Bax J, Woutersen RA, van Iersel P, van Kreijl CF, Scherer E. Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. Carcinogenesis 1991; 12: 1477-1482.
12. Pour PM, Uchida E, Burnett DA, Steplewski Z. Blood-group antigen expression during pancreatic cancer induction in hamsters. Int J Pancreatology 1986; 1: 327-340.
13. Egami H, Takiyama Y, Chaney WG, Cano M, Fujii H, Tomioka T, Metzgar R, Pour PM. Comparative studies on expression of tumor-associated antigens in human and induced pancreatic cancer in Syrian hamsters. Int J Pancreatology 1990; 6: 91-100.
14. Hirota M, Pour PM, Tempero MA, Chaney WG. Purification and analysis of glycoproteins bearing blood group-A determinants from hamster pancreatic ductal adenocarcinomas. Carcinogenesis 1992; 13: 1829-1833.
15. Hirota M, Mogaki M, Pour PM, Chaney WG. Glycan structure of blood group-A antigen in hamster normal tissues and pancreatic cancers. Exp Mol Pathol 1993; 58: 169-178.
16. Rouger Ph, Goossens D, Gane P, Salmon Ch. Distribution of blood group antigens in adult pancreas. Tissue Antigens 1981; 18: 51-55.
17. Uchida E, Steplewski Z, Mroczek E, Buchler M, Burnett D, Pour PM. Presence of two distinct acinar cell populations in human pancreas based on their antigenicity. Int J Pancreatology 1986; 1: 213-225.
18. Philipsen EK, Jorgensen M, Dabelsteen E. Expression of blood group-related carbohydrate antigens in normal human pancreatic tissue. APMIS 1991; 99: 931-940.
19. Schuessler MH, Pintado S, Welt S, Real FX, Xu M, Melamed MR, Lloyd KO, Oettgen HF. Blood group and blood-group-related antigens in normal pancreas and cancer. Int J Cancer 1991; 47: 180-187.
20. Egami H, Takiyama Y, Cano M, Houser WH, Pour PM. Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. Carcinogenesis 1989; 10: 861-869.
21. Hirota M, Mogaki M, Pour PM, Chaney WG. Modification of blood group A antigen expression in a pancreatic cancer cell line (PC-1) by inhibitors of N-glycan processing. J Cell Biochem 1992; 50: 13-20.
22. Itzkowitz SH, Yuan M, Ferrel LD, Ratcliffe RM, Chung Y-S, Satake K, Umeyama K, Jones RT, Kim YS. Cancer-associated alterations of blood group antigen expression in the human pancreas. JNCI 1987; 79: 425-434.
23. Pour PM, Tempero MM, Takasaki H, Uchida E, Takiyama Y, Burnett DA, Steplewski Z. Expression ofblood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res 1988; 48: 5422-5426.
24. Annese V, Minernini M, Gabbrielli A, Gambassi G, Manna R. ABO blood groups and cancer of the pancreas. Int J Pancreatology 1990; 6: 81-88.
25. Feizi T, Turberville C, Westwood JH. Blood group precursors and cancer-related antigens. Lancet 1975; 2: 391-393.
26. Drewinko B, Lichtiger B. Full expression of blood group-related transplantation-related, and carcinoembryonic antigens in human colorectal cells with different degrees of phenotypic differentiation. Cancer Res 1985; 45: 1560-1564.
27. Hakomori S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res 1985; 45: 2405-2414.
28. Yuan M, Itzkowitz S, Palekar A, Shamsuddin A, Phelps P, Trump B, Kim Y. Distribution of blood group antigens A, B, H, Lewis a and Lewis b in human normal, fetal, and malignant colonic tissue. Cancer Res 1985; 45: 4495-4511.
29. Schoentag R, Primus FJ, Kuhns W. ABH and lewis blood group expression in colorectal carcinoma. Cancer Res 1987; 47: 1695-1700.
30. Sakamoto J, Furukawa K, Cordon-Cardo C, Yin BWT, Rettig WJ, Oettgen HF, Old LJ, Lloyd KO. Expression of Lewis a, Lewis b, X and Y blood-group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res 1986; 46: 1553-1561.
31. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Ann Rev Biochem 1985; 54: 631-664.
32. Elbein AD. Glycosidase inhibitors: inhibitors of N-linked oligosaccharide processing. FASEB J 1991; 5: 3055-3063.
33. Humphries MJ, Matsumoto K, White SL, Olden K. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc Natl Acad Sci USA 1986; 83: 1752-1756.
34. Hughes C, Foddy L, Bause E. Asparagine-linked oligosaccharides of BHK cells treated with inhibitors of oligosaccharide processing. Biochem J 1987; 247: 537-545.
35. Plummer TH Jr, Elder JH, Alexander S, Phelan AW, Tarentino AL. Demonstration of peptide:N-glycosidase F activity in endo-β-N-acetylglucosaminidase F preparations. J Biol Chem 1984; 259: 10,700-10,704.
36. Tarentino AL, Gomez CM, Plummer TH Jr. Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F. Biochemistry 1985; 24: 4665-4671.
37. Kim YW, Kern HF, Mullins TD, Koriwchak MJ, Metzgar RS. Characterization of clones of a human pancreatic adenocarcinoma cell line representing different stages of differentiation. Pancreas 1989; 4: 353-362.
38. Fogh J, Wright WC, Loveless JD. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 1977; 58: 209-214.
39. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
40. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
41. Trimble RB, Maley F. Optimizing hydrolysis of N-linked high-mannose oligosaccharides by endo-β-N-acetylglucosaminidase H. Anal Biochem 1984; 141: 515-522.
42. Alexander S, Elder JH. Endoglycosidases from Flavobacterium meningosepticum - Application to biological problems. Methods Enzymol 1989; 179: 505-518.
43. Cummings RD, Kornfeld S. Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. J Biol Chem 1982; 257: 11,230-11,234.
44. Osawa T, Tsuji T. Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Ann Rev Biochem 1987; 56: 21-42.
45. Laferte S, Dennis JW. Purification of two glycoproteins expressing β1-6 branched Asn-linked oligosaccharides from metastatic tumour cells. Biochem J 1989; 259: 569-576.